As biomarkers are one of the ultimate solutions to optimize novel drug research through analytical and clinical R&D, it is key to ensure the latest technologies and validated methods are used under a GLP and GCP environment. For many years, SGS Life Science Services bioanalytical team has invested significant resources to bring its clients the best-in-class biomarker services, such as:

  • The automated Cobas 6000 Analyzer System enables fast determination of a large number of biological parameters (biomarkers), metabolites and compounds with high precision, and accuracy. Up to ten assays can be conducted in parallel, offering great saving on the volume of clinical samples required, while reducing turnaround time for customers. The immunology and chemistry modules complement our bioanalytical systems to further extend our broad biomarker portfolio covering a range of therapeutic areas.
  • The upgraded version, Luminex FLEXMAP 3D allows faster and more sensitive analysis than current Bioplex 200. This instrument is 21 CFR Part 11 and GCP compliant and offers higher throughput for biomarker testing with a capacity to run up to 500 assays in a single run.
  • A full analytical validation of the novel Meso Scale Discovery (MSD®) V-PLEX 10-plex Proinflammatory Panel I, for testing in human samples. The validation included measurement of precision, accuracy, dilutional linearity, and stability. These cytokines are key in inflammatory response and immune system regulation, as well as numerous other disorders involving Th1/Th2 activation such as rheumatoid arthritis, Alzheimer’s disease, asthma, atherosclerosis, diabetes, psoriasis, Crohn’s disease etc.

For further information please contact:

SGS Life Science Services
90, avenue des Hauts de la Chaume
BP 28
Saint-Benoît cedex, 86281
t: +33 (0) 5 49 57 04 04 
f: +33 (0) 5 49 57 22 39